In keeping with our mission to provide comprehensive advertising analysis, MediaRadar puts together a report of the most important mergers and acquisitions news each week. Stay in the loop, whether you sell advertising space or focus on business development.
This week, Intel moved closer to the cloud gaming platform market by acquiring RemoteMyApp. Qualcomm purchased Clay AIR and NovaBay acquired skin-care product developer DERMAdoctor.
Intel Corporation announced that it has acquired RemoteMyApp, a start-up based in Szczecin, Poland that provides cloud gaming solutions. The financial terms of the deal were not disclosed; however, RemoteMyApp raised around $4.7 million prior to the acquisition.
Founded in 2014, RemoteMyApp provides enterprises with game streaming technology. The start-up’s platform provides the backend infrastructure so that companies can create apps and interfaces and admin solutions.
The cloud gaming market is very competitive, with top players such as Amazon, Google, Nvidia, and Sony. Intel has not signaled its intent to launch its own cloud gaming platform, but combining RemoteMyApp’s products with its existing hardware to create a chip and service package could be an alternative entry into the market.
Chipmaker Qualcomm Technologies announced that it has acquired Clay AIR, a hand-tracking and gesture recognition startup.
Founded in 2014, Clay AIR’s software enables hardware providers to offer interactions with kiosks, in-car displays, and many different consumer electronics.
The acquisition was announced alongside the launch of Qualcomm’s Snapdragon Spaces developer platform, which is used to help developers build apps and experiences for Qualcomm-powered AR glasses.
NovaBay Pharmaceuticals, Inc. announced that it closed the acquisition of DERMAdoctor, LLC for $15 million.
Founded in 1998, DERMAdoctor is a privately-held company that commercializes dermatologist-developed skin care products. The company produces more than 30 products under brand names such as Ain’t Misbehavin’, Calm Cool + Corrected, and Wrinkle Revenge.
NovaBay CEO Justin Hall said that the addition of DERMAdoctor “will significantly increase NovaBay’s presence in the U.S. beauty market” and help support its “goals of reaching profitability and enhancing stockholder value.”
Other deals and developments are taking place: